EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reliability assessment using the test–retest method and minimal important changes in the Adult Fabry Disease Quality of Life Scale

Yuta Koto iD, Masami Tanaka iD, Mitsuyo Ishiura, HyeSook Kim, Atsushi Ohashi, Nozomi Hadano iD, Aya Narita, Norio Sakai

Therapeutic Advances in Rare Disease · 2026-03 · 7

DOI: 10.1177/26330040261433034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Rare Disease, online erschienen am 23.03.2026. Verfasst von Yuta Koto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nursing, Kansai Medical University, 2-2-2 Shinmachi, Hirakata, Osaka 573-1004, Japan. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: japan society for the promotion of science, Japanese Society of Inherited Metabolic Disease/Sanofi LSD Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fabry disease is rare and multisystemic, necessitating a disease-specific quality of life scale to assess changes in quality of life. We developed the Adult Fabry Disease Quality of Life scale to measure the quality of life of adult patients with Fabry disease.

Objectives

To confirm the reliability of the Adult Fabry Disease Quality of Life scale using the test–retest method and calculate the minimal important change.

Design

This study was based on two questionnaire surveys conducted at approximately 2-week intervals in November and December 2024 in Japan.

Methods

Twenty-eight participants completed questionnaires consisting of background information, the Adult Fabry Disease Quality of Life scale, and the Short Form-8. In the second survey, an anchor question with a 7-point Likert scale was added to assess changes in general health. The intraclass correlation coefficient for reliability and Cronbach’s alpha coefficient for internal consistency were calculated. For minimal important changes, the average value of the smallest change group for the anchor question was calculated.

Results

The intraclass correlation coefficients for each factor and the total score on the Adult Fabry Disease Quality of Life scale were 0.892–0.946. Cronbach’s alpha coefficient was 0.948 for the first survey and 0.956 for the second. In response to the anchor question, three participants (13.0%) felt a little worse, and three (13.0%) felt a little better. Those who felt a little worse and those who felt a little better showed improvements in quality of life of 3.7 and 5.3 points, respectively.

Conclusion

The Adult Fabry Disease Quality of Life scale is highly reproducible at 2-week intervals. Defining the minimum important change was not possible, which is important when used as an outcome. Future studies should establish it using the anchor method. Trial Registration: This prospective study was registered with the UMIN-CTR on September 1, 2024 (No. UMIN000055144).

Schlagwörter

Stichwörter der Autor:innen

Fabry diseaselysosomal storage diseasesminimal clinically important differencesquality of life

Autor:innen und Institutionen

  • Faculty of Nursing, Kansai Medical University, 2-2-2 Shinmachi, Hirakata, Osaka 573-1004, Japan.
  • Faculty of Nursing, Kansai Medical University, Hirakata City, Osaka, Japan.
  • Department of Nursing, Faculty of Nursing, Shitennoji University, Habikino City, Osaka, Japan.
  • Center for Promoting the Treatment of Intractable Diseases, ISEIKAI International General Hospital, Osaka City, Osaka, Japan.
  • Pediatrics, ISEIKAI International General Hospital, Osaka City, Osaka, Japan.

ORCID-Profile: Yuta Koto, Masami Tanaka, Nozomi Hadano

Förderung

  • japan society for the promotion of science
  • Japanese Society of Inherited Metabolic Disease/Sanofi LSD Research Grant

Zitieren

APA

Koto, Y., Tanaka, M., Ishiura, M., Kim, H., Ohashi, A., Hadano, N., Narita, A., & Sakai, N. (2026). Reliability assessment using the test–retest method and minimal important changes in the Adult Fabry Disease Quality of Life Scale. Therapeutic Advances in Rare Disease, 7. https://doi.org/10.1177/26330040261433034

Vancouver

Koto Y, Tanaka M, Ishiura M, Kim H, Ohashi A, Hadano N, et al. Reliability assessment using the test–retest method and minimal important changes in the Adult Fabry Disease Quality of Life Scale. Therapeutic Advances in Rare Disease. 2026;7. doi:10.1177/26330040261433034

BibTeX
@article{Koto2026,
  author = {Koto, Yuta and Tanaka, Masami and Ishiura, Mitsuyo and Kim, HyeSook and Ohashi, Atsushi and Hadano, Nozomi and Narita, Aya and Sakai, Norio},
  title = {Reliability assessment using the test–retest method and minimal important changes in the Adult Fabry Disease Quality of Life Scale},
  journal = {Therapeutic Advances in Rare Disease},
  year = {2026},
  volume = {7},
  doi = {10.1177/26330040261433034}
}
Kostenlos starten →